Northrop Grumman (NOC) Is Down This Year and Trades Below Its History and Peers. Time to Buy the Dip?
Northrop Grumman (NOC) shares are down 11% YTD, trading below historical and sector valuations. The company reported Q2 sales of $10.88B, up 10% sequentially, and raised full-year guidance. Operating margins declined, but backlog grew to $105B. Analysts debate whether the stock's discount is justified or presents a buying opportunity.
How this was made

The 30-second read
Why it matters
It frames the stock as a potential value opportunity tied to a margin recovery in 2H 2026, while emphasizing near-term risks from margin pressure, contract losses, and program charges.
Market read
Traders get a guidance update plus the margin and charge context, but the article is still largely a valuation and thesis discussion ahead of the next earnings print.
What to watch
The article cites a tax-rate explanation for the EPS beat and highlights capex ramp for B-21 production, both of which can complicate how quickly free cash flow and margins normalize.
Background
The piece argues the defense demand cycle is strong, yet Northrop Grumman’s shares are down over 11% YTD, trading below its own and the sector’s valuation history.
Ticker impact
Northrop Grumman reported Q2 results and lifted full-year sales and adjusted EPS guidance, while margin fell to 10.1% and backlog hit a record $105B.
Likely mixed-to-negative near term as investors weigh margin weakness and charges against the guidance increase and backlog strength.
The article’s decision-relevant items are the guidance raise (positive) and the margin decline plus specific program charge (negative), with the thesis hinging on whether margins recover in 2H 2026.
Market effects
Defense primes may trade on margin durability and fixed-price program risk even amid strong demand cycles.
Primarily US defense equities sentiment, with potential read-through to US defense procurement expectations.
Global NATO spending tailwinds support the group, but execution risk can still drive valuation dispersion.
Counterpoint
The valuation discount may reflect structural margin headwinds from fixed-price exposure and recurring program charges, not a temporary dip.
Key entities
- companyNorthrop Grumman Corporation
Defense prime reporting Q2 results, lifting full-year guidance, and facing margin pressure and program charges.
- programGEM 63XL program
Cited as having an unfavorable $91 million charge in the quarter, contributing to margin weakness.
- programB-21 Raider
Production ramp cited as driving future capex and potential free-cash-flow impacts.

